The Impact of Off-Label, Compassionate and Unlicensed Use on Health Care Laws in Preselected Countries

The Impact of Off-Label, Compassionate and Unlicensed Use on Health Care Laws in Preselected Countries

by Vanessa Plate

Paperback

$39.00
Eligible for FREE SHIPPING
  • Want it by Wednesday, October 24?   Order by 12:00 PM Eastern and choose Expedited Shipping at checkout.

Overview

The Impact of Off-Label, Compassionate and Unlicensed Use on Health Care Laws in Preselected Countries by Vanessa Plate

In times of situational therapeutic impasse, health care professionals (HCPs) are under pressure to conduct off-label, unlicensed and compassionate drug use—generally summarized under the term non-licensed drug use (NDU). Liability, contractual and penal risks pose a problem when treating a patient in a non-licensed way. There is a knowledge gap about institutional and governmental methods to resolve these problems. Different countries have developed strategies to manage NDU. Vanessa Platé gives a comprehensive overview of practices Canada, the U.S., the U.K., Japan, France, Germany, Switzerland, Austria, and the transnational E.U. A must-read for everyone interested in the discussion on how to administer the best treatment, especially regarding early access to yet unapproved treatments.

Product Details

ISBN-13: 9783838201351
Publisher: ibidem Press
Publication date: 07/01/2010
Pages: 176
Product dimensions: 5.83(w) x 8.27(h) x 0.38(d)
Age Range: 18 Years

About the Author

Vanessa Platé is a pharmacist specializing in drug information. She was part of the research group Drug Regulatory Affairs. In this function, Platé did extensive research on NDU on behalf of the German Federal Ministry of Health.

Table of Contents

Abstract
1. Introduction
2. Methodology and Materials
3. Results
4. Discussion
Preliminary publications and presentations
Appendix
Bibliography

Customer Reviews

Most Helpful Customer Reviews

See All Customer Reviews